3rd Circ. To Review Venue Ruling In GSK Birth Defects Case
Earlier this month, GSK challenged the plaintiffs' Dec. 23 petition for permission to appeal the company's removal of the case to federal court following a landmark Third Circuit ruling in June keeping a separate suit over GSK's morning-sickness drug thalidomide in federal court.
The company argued that...
To view the full article, register now.